Exhibit 1.01
Conflict Minerals Report
Enovis
Corporation has included this Conflict Minerals Report as an exhibit to its Form SD for the period from January 1, 2023 to December 31, 2023 as provided for in Rule 13p-1 under the Securities
Exchange Act of 1934, as amended, and Form SD (collectively, the Conflict Minerals Rule). Unless the context indicates otherwise, the terms Enovis, we, its, us, and our refer to
Enovis Corporation and its consolidated subsidiaries. As used herein, Conflict Minerals or 3TG is defined as, consistent with the Conflict Minerals Rule, cassiterite, columbite-tantalite (coltan), gold, wolframite and the
derivatives tin, tantalum and tungsten.
Forward-Looking Statements
This document contains forward-looking statements within the meaning of the federal securities laws. Any statements that do not relate to historical or current
facts or matters are forward-looking statements. You can identify some of the forward-looking statements by the use of forward-looking words, such as intend and the like, or the use of future tense. Statements concerning current
conditions may also be forward-looking if they imply a continuation of current conditions. Examples of forward-looking statements include, but are not limited to, statements concerning the additional steps that we intend to take to mitigate the risk
that our necessary 3TG benefit armed groups.
Forward-looking statements are subject to risks and uncertainties that could cause actual actions or
performance to differ materially from those expressed in the forward-looking statements. These risks and uncertainties include, but are not limited to, (1) the continued implementation of satisfactory traceability and other compliance measures
by our direct and indirect suppliers on a timely basis or at all, (2) whether smelters and refiners and other market participants responsibly source 3TG, and (3) political, regulatory and economic developments, whether in the Democratic
Republic of the Congo (DRC) region (the Covered Countries), the United States or elsewhere. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of filing of this
document. We do not intend, and undertake no obligation, to publish revised forward-looking statements to reflect events or circumstances after the date of filing of this document or to reflect the occurrence of unanticipated events.
Company and Product Information
Enovis Corporation is an
innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent
and innovation, our extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond.
Our continuing in-scope product categories for 2023 were orthopedic devices. For a further discussion of our products, see our Annual Report on Form 10-K for the year ended December 31,
2023. The information contained in our Form 10-K and other external materials referenced herein, including our website, is not incorporated by reference into this Conflict Minerals Report or our Form SD and
should not be considered part of this Conflict Minerals Report or the Form SD.
Applicability of the Conflict Minerals Rule to Our Company
We are subject to the Conflict Minerals Rule because some of the products that we manufacture contain 3TG that are necessary to their functionality or
production. Our in-scope products contain tin, tantalum, tungsten and gold, although no in-scope product contains all four 3TG.
We generally do not source 3TG from smelters or refiners and have no direct relationships with mines, and we believe that we are in most cases many levels
removed from all of these market participants. However, through the efforts described in this Conflict Minerals Report, we seek to ensure that our sourcing practices are consistent with our Conflict Minerals Policy, which is described below, and
encourage conflict free sourcing in our supply chain.
1